Scarica l'app Stockscreener
1.94
0.52%
0.01
Dopo l'orario di chiusura:
1.93
-0.01
-0.52%
Precedente Chiudi:
$1.93
Aprire:
$1.96
Volume 24 ore:
369.62K
Relative Volume:
0.25
Capitalizzazione di mercato:
$164.89M
Reddito:
-
Utile/perdita netta:
$-59.69M
Rapporto P/E:
-1.3957
EPS:
-1.39
Flusso di cassa netto:
$-46.54M
1 W Prestazione:
+0.00%
1M Prestazione:
+14.12%
6M Prestazione:
-5.37%
1 anno Prestazione:
+25.97%
Intervallo 1D:
$1.92
$1.97
Intervallo di 1 settimana:
$1.88
$2.04
Portata 52W:
$0.6254
$2.75
Milestone Pharmaceuticals Inc Stock (MIST) Company Profile
Nome
Milestone Pharmaceuticals Inc
Settore
Industria
Telefono
(514) 336-0444
Indirizzo
1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420, MONTREAL, QC
Confronta MIST con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MIST
Milestone Pharmaceuticals Inc
|
1.94 | 164.04M | 0 | -59.69M | -46.54M | -1.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
376.62 | 97.36B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
576.98 | 60.19B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
458.37 | 59.56B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
729.76 | 44.94B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
329.84 | 36.14B | 3.81B | -644.79M | -669.77M | -6.24 |
Milestone Pharmaceuticals Inc Stock (MIST) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-11 | Iniziato | Wells Fargo | Overweight |
| 2025-06-05 | Ripresa | H.C. Wainwright | Buy |
| 2024-08-22 | Iniziato | Rodman & Renshaw | Buy |
| 2023-06-20 | Downgrade | Jefferies | Buy → Hold |
| 2022-04-22 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2021-03-05 | Iniziato | H.C. Wainwright | Buy |
| 2020-07-29 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2020-07-24 | Aggiornamento | Jefferies | Hold → Buy |
| 2020-03-25 | Downgrade | Jefferies | Buy → Hold |
| 2020-03-24 | Downgrade | Oppenheimer | Outperform → Perform |
| 2020-03-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2019-06-04 | Iniziato | Oppenheimer | Outperform |
| 2019-06-03 | Iniziato | Cowen | Outperform |
| 2019-06-03 | Iniziato | Jefferies | Buy |
| 2019-06-03 | Iniziato | Piper Jaffray | Overweight |
Mostra tutto
Milestone Pharmaceuticals Inc Borsa (MIST) Ultime notizie
How hedge fund analytics apply to Milestone Pharmaceuticals Inc. stock2025 Top Decliners & Community Consensus Trade Signals - newser.com
Real time scanner hits for Milestone Pharmaceuticals Inc. explainedMarket Sentiment Review & Safe Capital Preservation Plans - newser.com
Recursion Pharmaceuticals, Inc. (RXRX) Secures $12.5M Milestone From Rallybio as REV102 Advances - Yahoo Finance
Downgrade Watch: Can Milestone Pharmaceuticals Inc. outperform under higher oil prices - خودرو بانک
Will a bounce in Milestone Pharmaceuticals Inc. offer an exitWeekly Trend Summary & AI Based Trade Execution Alerts - newser.com
AI Stocks: Should you buy the dip on EPAMWeekly Gains Report & AI Enhanced Trading Alerts - khodrobank.com
Chart based analysis of Milestone Pharmaceuticals Inc. trendsJuly 2025 Short Interest & Weekly Breakout Opportunity Watchlist - newser.com
Sectors Review: Is Milestone Pharmaceuticals Inc. stock showing strong momentumJuly 2025 Setups & Smart Investment Allocation Tips - خودرو بانک
Leading vs lagging indicators on Milestone Pharmaceuticals Inc. performanceTrade Risk Summary & Weekly High Return Stock Opportunities - newser.com
Gains Report: What is Milestone Pharmaceuticals Incs book value per shareGap Down & Stock Portfolio Risk Management - خودرو بانک
Gains Report: What are the risks of holding Milestone Pharmaceuticals Inc2025 Retail Activity & Smart Allocation Stock Tips - خودرو بانک
Applying Elliott Wave Theory to Milestone Pharmaceuticals Inc.Earnings Growth Report & Trade Opportunity Analysis Reports - newser.com
Is Milestone Pharmaceuticals Inc. building a consolidation baseLong Setup & Real-Time Stock Entry Alerts - newser.com
VIX Spike: What is the PEG ratio of Braskem S.A. Depositary ReceiptInsider Buying & Accurate Buy Signal Alerts - خودرو بانک
Sectors Review: Does SONN have a sustainable dividendPrice Action & Entry Point Confirmation Alerts - khodrobank.com
Pullback Watch: Should I invest in TAVIU before earningsPortfolio Profit Report & AI Enhanced Trading Signals - خودرو بانک
Panic Selling: Can Milestone Pharmaceuticals Inc outperform under higher oil pricesJuly 2025 Trends & Smart Money Movement Alerts - خودرو بانک
Gains Recap: Is Milestone Pharmaceuticals Incs ROIC above industry averageDollar Strength & Advanced Swing Trade Entry Alerts - khodrobank.com
Analysts Set Milestone Pharmaceuticals Inc. (NASDAQ:MIST) Target Price at $4.50 - MarketBeat
Aug Decliners: Should I invest in Milestone Pharmaceuticals Inc before earningsJuly 2025 Drop Watch & High Accuracy Swing Entry Alerts - khodrobank.com
Trend Recap: Is Milestone Pharmaceuticals Inc undervalued by DCF analysisJuly 2025 Short Interest & High Return Trade Guides - خودرو بانک
MIST Stock Falls 66% Following Complete Response Letter for Cardamyst - MSN
Key resistance and support levels for Milestone Pharmaceuticals Inc.Trade Exit Summary & Weekly High Return Forecasts - newser.com
Milestone Pharmaceuticals Inc. stock daily chart insightsJuly 2025 Highlights & Real-Time Market Sentiment Alerts - newser.com
Candlestick signals on Milestone Pharmaceuticals Inc. stock todayBull Run & Verified Stock Trade Ideas - newser.com
Analysts Offer Insights on Healthcare Companies: Kala Pharmaceuticals (KALA) and Milestone Pharmaceuticals (MIST) - The Globe and Mail
Milestone Pharmaceuticals (NASDAQ:MIST) Now Covered by Wells Fargo & Company - MarketBeat
Market Review: Is Milestone Pharmaceuticals Inc. stock showing strong momentumPortfolio Gains Summary & Free AI Powered Buy and Sell Recommendations - خودرو بانک
Published on: 2025-09-15 23:10:01 - newser.com
Institutional scanner results for Milestone Pharmaceuticals Inc.Market Sentiment Summary & Smart Investment Allocation Tips - newser.com
Ranking Milestone Pharmaceuticals Inc. among high performing stocks via toolsMarket Performance Summary & Technical Confirmation Trade Alerts - newser.com
Published on: 2025-09-15 06:01:13 - newser.com
Analyst Upgrade: Can Milestone Pharmaceuticals Inc. be the next market leader2025 Volume Leaders & Stock Timing and Entry Methods - khodrobank.com
Dividend Watch: Can Milestone Pharmaceuticals Inc outperform under higher oil pricesJuly 2025 Highlights & Daily Market Momentum Tracking - خودرو بانک
Is Milestone Pharmaceuticals Inc. stock ready for a breakoutJuly 2025 Levels & Reliable Entry Point Alerts - newser.com
Published on: 2025-09-14 22:22:11 - newser.com
Applying chart zones and confluence areas to Milestone Pharmaceuticals Inc.Weekly Market Outlook & Daily Volume Surge Trade Alerts - newser.com
Published on: 2025-09-14 12:46:22 - newser.com
Milestone Pharmaceuticals Inc. (NASDAQ:MIST) Receives $4.50 Consensus Target Price from Brokerages - Defense World
Wells Fargo Initiates Coverage on MIST with Overweight Rating | - GuruFocus
Wells Fargo initiates Milestone Pharmaceuticals stock with Overweight rating By Investing.com - Investing.com Canada
Wells Fargo Initiates Milestone Pharmaceuticals(MIST.US) With Buy Rating, Announces Target Price $4 - 富途牛牛
Will Breakout in Milestone Pharmaceuticals Inc. Sustain Through Next WeekVolume Spike & AI Powered Market Trend Analysis - beatles.ru
Can Milestone Pharmaceuticals Inc. be the next market leaderCEO Change & Real-Time Buy Signal Alerts - خودرو بانک
Is Milestone Pharmaceuticals Inc. likely to announce a buybackMarket Performance Summary & Free Safe Entry Trade Signal Reports - خودرو بانک
Has Milestone Pharmaceuticals Inc. found a price floor2025 Trading Recap & Daily Stock Trend Reports - Newser
What is Milestone Pharmaceuticals Inc. s 5 year growth outlookQuarterly Trade Summary & Growth Oriented Trade Recommendations - خودرو بانک
Short interest data insights for Milestone Pharmaceuticals IncWeekly Loss Report & Technical Analysis for Trade Confirmation - Newser
Tools to assess Milestone Pharmaceuticals Inc.’s risk profileJuly 2025 Gainers & Low Drawdown Momentum Trade Ideas - Newser
Live market analysis of Milestone Pharmaceuticals Inc.Sell Signal & Low Drawdown Trading Techniques - Newser
Propel Bio Management LLC Takes $1.16 Million Position in Milestone Pharmaceuticals Inc. $MIST - MarketBeat
Milestone Pharmaceuticals Inc Azioni (MIST) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.30%
2.51%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):